Apple to Strip Key Health Function from Watch Series.
In a significant turn of events, Apple is set to exclude a vital health feature, pulse oximetry, from its latest Watch models due to a ruling by the US Court of Appeals for the Federal Circuit.
This decision follows an ongoing legal clash with health technology firm Masimo, alleging patent infringement in blood analysis technology.
The dispute led to a temporary ban on Apple Watch sales during Christmas, and the recent court verdict prevented the sale of the disputed models.
Read More: US Bans Popular Watch Series 9 and Ultra 2
Despite Apple’s disagreement, it will comply with the ruling, impacting its position in the wearables market. Existing Watches are unaffected by the change.
Apple Watches commands approximately 25% of the global smartwatch market, as per Counterpoint Research. The recent court decision resulted in a 0.5% dip in Apple’s shares, closing at $182.68.
Analysts suggest that the exclusion of the blood oxygen feature may impact Apple’s sales in the health and fitness-oriented wearables segment.
Read More: Apple to Launch Vision Pro Headset on Feb 2
The Series 9 and Ultra 2 models, available in the U.S. from Thursday, maintain the appearance of previous models. However, the blood oxygen feature appears to be disabled in the software.
Users attempting to access the blood oxygen app will receive a notification that the functionality is no longer accessible.
Note: The information above might not be accepted 100%. Please verify from your own sources. We will not be responsible for any kind of loss due to our content.
For more news, please visit Munafa Marketing.
